ONESOURCE
Onesource Specialty Pharma Limited (ONESOURCE) Stock Analysis
Onesource Specialty Pharma Limited develops and manufactures complex injectables and specialty formulations for regulated markets. It focuses on sterile and differentiated dosage forms for partners and own brands. The company targets high-barrier pharmaceutical niches. It is listed on Indian stock exchanges in the pharma sector.
Healthcare › Biotechnology
₹1,407.80
-3.66% 1W | -21.20% 52W
Market Cap
16.1k CR
P/E Ratio
–
52W High
₹1925
52W Low
₹1057
Div. Yield
0%
Beta
–
50 DMA
₹1544.9
200 DMA
₹1555.9
Profit Margin
-3.1%
Inst. Own.
33.4%
⚠️ BREAKDOWN
⚠️ BREAKDOWN
Fundamentals
Profit & Loss
| Metric | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 34 | 56 | 73 | 292 | 334 | 393 | 426 | 327 | 376 | 290 | 428 | 449 |
| Expenses | 72 | 67 | 76 | 228 | 257 | 251 | 243 | 239 | 269 | 273 | 336 | 326 |
| Operating Profit | -39 | -10 | -3 | 64 | 77 | 142 | 183 | 88 | 106 | 17 | 92 | 123 |
| OPM % | -114% | -19% | -3.8% | 22% | 23% | 36% | 43% | 27% | 28% | 6% | 21% | 27% |
| Other Income | -32 | -74 | 3 | -1 | -1 | -94 | 2 | 2 | 3 | -2 | 2 | -0 |
| Interest | 25 | 26 | 20 | 42 | 45 | 46 | 33 | 27 | 34 | 38 | 23 | 31 |
| Depreciation | 18 | 20 | 20 | 68 | 68 | 69 | 68 | 68 | 70 | 70 | 72 | 72 |
| Profit before tax | -114 | -130 | -40 | -47 | -37 | -67 | 83 | -4 | 6 | -93 | -0 | 20 |
| Tax % | 0% | 0% | 0% | -88% | 12% | 4% | -19% | -96% | -83% | -5% | -1,630% | -23% |
| Net Profit | -114 | -130 | -40 | -6 | -42 | -69 | 98 | -0 | 10 | -89 | 5 | 25 |
| EPS in Rs | -6.02 | 8.61 | -0.02 | 0.92 | -7.74 | 0.40 | 2.18 |
| Metric | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|
| Sales | 21 | 132 | 39 | 172 | 1,445 | 1,422 | 1,543 |
| Expenses | 93 | 229 | 199 | 254 | 978 | 1,117 | 1,204 |
| Operating Profit | -71 | -97 | -161 | -82 | 467 | 304 | 339 |
| OPM % | -334% | -73% | -415% | -48% | 32% | 21% | 22% |
| Other Income | 1 | 4 | -526 | -143 | -94 | 5 | 2 |
| Interest | 16 | 68 | 48 | 89 | 166 | 122 | 126 |
| Depreciation | 34 | 70 | 66 | 76 | 274 | 279 | 283 |
| Profit before tax | -121 | -231 | -800 | -391 | -68 | -92 | -67 |
| Tax % | 0% | -0% | 0% | 0% | -73% | -20% | |
| Net Profit | -121 | -231 | -800 | -391 | -18 | -74 | -49 |
| EPS in Rs | -1.57 | -6.44 | -4.24 | ||||
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% |
Growth — CAGR
| Metric | 3Y | 5Y | 10Y |
|---|---|---|---|
| Revenue CAGR | 232.0% | 131.0% | – |
| Profit CAGR | 24.0% | 8.0% | – |
Shareholding Pattern
Promoters29.78%
FIIs18.69%
DIIs18.09%
Public33.42%
Promoters29.77%
FIIs19.39%
DIIs18.48%
Public32.34%
Promoters29.93%
FIIs19.24%
DIIs18.80%
Public32.01%
Promoters30.48%
FIIs17.50%
DIIs20.61%
Public31.40%
Promoters30.48%
FIIs19.19%
DIIs23.37%
Public26.95%
Promoters34.25%
FIIs18.54%
DIIs18.03%
Public29.17%
Promoters30.48%
FIIs17.50%
DIIs20.61%
Public31.40%
Promoters30.48%
FIIs19.19%
DIIs23.37%
Public26.95%
ONESOURCE
Holdings Analysis
Key strengths & risk signals
46
Overall
46
Fundamental
47
Technical
Risks (4)
Cannot calculate PEG - insufficient growth data.
POOR YEAR! Stock declined 21.2% in the last year.
WEAK POSITION! Current price (1407.8) is below both moving averages.
NEGATIVE MOMENTUM! Price declined across timeframes - down 3.7% (1 week), 11.8% (1 month), 14.8% (3 months).
Strengths (3)
APPROACHING OVERSOLD! RSI at 30.4 - watch for reversal.
BULLISH SENTIMENT! In last 30 days: 13 up days, 17 down days. Avg volume on up days: 359,790 vs down days: 324,532. Ratio: 1.11x
MID RANGE! Trading at 40.4% of 52W range - neutral zone.
Fundamental & Technical Analysis
46Overall
46Fundamental
47Technical
Fundamental Breakdown
Growth Quality
17/30
Revenue CAGR: 232.4% (EXCELLENT, 15/15). Profit CAGR: 0% (DECLINING, 2/15).
Profit Margin
2/10
LOW MARGIN! -3.1% profit margin - thin profits.
PEG Valuation
0/10
Cannot calculate PEG - insufficient growth data.
Dividend Yield
3/10
NEGLIGIBLE DIVIDEND! 0% yield - little to no income.
Debt to Equity
10/10
VERY LOW DEBT! D/E of 0.00 - excellent financial health.
Public Holding
10/20
SIGNIFICANT PUBLIC HOLDING! 32.24% public ownership - moderate retail influence.
Stability Index
4/10
CAREFUL! Company does not have stable profit track. 2 loss-making quarters detected.
Technical Breakdown
Moving Averages
3/10
BEARISH TREND! 50-day average (1544.9) is below 200-day average (1555.9) - negative signal.
Price Position
2/10
WEAK POSITION! Current price (1407.8) is below both moving averages.
Trend Pattern
10/20
BREAKDOWN! Stock has broken below support levels - weakness present.
52W Performance
1/10
POOR YEAR! Stock declined 21.2% in the last year.
Volume Sentiment
20/30
BULLISH SENTIMENT! In last 30 days: 13 up days, 17 down days. Avg volume on up days: 359,790 vs down days: 324,532. Ratio: 1.11x
RSI
4/5
APPROACHING OVERSOLD! RSI at 30.4 - watch for reversal.
52W Range
3/5
MID RANGE! Trading at 40.4% of 52W range - neutral zone.
Momentum
1/5
NEGATIVE MOMENTUM! Price declined across timeframes - down 3.7% (1 week), 11.8% (1 month), 14.8% (3 months).
Beta
3/5
MARKET ALIGNED! Beta of 1.00 - moves with the market.
ONESOURCE
Concall / Investor Presentation
Earnings call transcripts & AI summaries
| Quarter | Concall | Summary |
|---|---|---|
| Q4FY262026-07-31 | Concall PDF | |
| Q3FY262026-01-30 | Concall PDF | |
| Q2FY262025-11-18 | Concall PDF |
Peer Comparison
Healthcare · Biotechnology · 8 stocks
| Stock | Price | P/E | Profit Margin | Revenue CAGR 5Y | Profit CAGR 5Y | 52W Change | Stock Strength | Trendline | YoY Profit | QoQ Profit | YoY Revenue | QoQ Revenue |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ONESOURCE | ₹1,407.80 | – | -3.1% | 232.4% | – | -21.2% | 46 | BREAKDOWN | -12,600.0% | +443.5% | +37.2% | +4.9% |
| CONCORDBIO | ₹1,339.00 | 45.2 | 24.8% | 8.0% | 2.8% | -9.7% | 55 | BREAKDOWN | +30.8% | -35.0% | +26.2% | -21.0% |
| BLUEJET | ₹520.60 | 38.4 | 26.5% | 9.4% | 15.7% | -22.2% | 70 | BREAKDOWN | -14.1% | +21.8% | -17.4% | +24.9% |
| SUPRIYA | ₹886.00 | 35.9 | 22.7% | 21.2% | 32.5% | +18.4% | 86 | CONSOLIDATING UP | -31.0% | -67.7% | +30.7% | -31.4% |
| ZOTA | ₹1,409.30 | – | -17.0% | 56.7% | – | -11.1% | 56 | CONSOLIDATING UP | +204.9% | +207.0% | +67.6% | +6.4% |
| DCAL | ₹149.80 | 146.9 | 0.6% | 9.0% | 21.0% | -45.7% | 50 | CONSOLIDATING DOWN | -347.9% | -367.3% | -4.2% | -20.4% |
| PANACEABIO | ₹359.70 | – | -1.1% | 10.1% | – | -20.0% | 48 | CONSOLIDATING DOWN | -42.5% | +360.0% | +19.7% | +19.7% |
| 3BBLACKBIO | ₹1,446.40 | 22.1 | 36.3% | 31.9% | 32.2% | +26.8% | 73 | APPROACHING RESISTANCE | -24.6% | -1.0% | +50.9% | -5.4% |
Data from TradeAlone · Updated daily
